OmicsBank raises $2.25M for cross-border patient data services
OmicsBank has secured $2.25 million in funding to provide biopharmaceutical companies with patient data from outside the US. The company aims to capitalize on the growing need for diverse health data to train AI models in drug discovery. The investment reflects increasing interest in data-driven approaches to accelerate development.
Related stories
Immunology Startup Boulevard Bio Raises $65M, Adds Chinese Drug Candidate to Pipeline · Drug development
Eli Lilly Cracks Down on Illicit Retatrutide Sales · Drug development
This summary is AI-generated and original to Mobble; the linked article is the authoritative source.
Original headline: “OmicsBank raises $2.25M to bring overseas patient data to biopharma.” Browse more stories.